company background image
PERP B logo

Perpetua Medical OM:PERP B Stock Report

Last Price

SEK 4.75

Market Cap

SEK 21.5m

7D

6.7%

1Y

415.4%

Updated

01 Nov, 2024

Data

Company Financials

Perpetua Medical AB (publ)

OM:PERP B Stock Report

Market Cap: SEK 21.5m

PERP B Stock Overview

Provides products and solutions for use of injectable drugs in Sweden.

PERP B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Perpetua Medical AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Perpetua Medical
Historical stock prices
Current Share PriceSEK 4.75
52 Week HighSEK 5.41
52 Week LowSEK 0.49
Beta2.12
11 Month Change6.74%
3 Month Change40.87%
1 Year Change415.41%
33 Year Change-97.89%
5 Year Change-97.97%
Change since IPO-98.90%

Recent News & Updates

Recent updates

Shareholder Returns

PERP BSE Medical EquipmentSE Market
7D6.7%-4.8%-1.4%
1Y415.4%5.6%20.7%

Return vs Industry: PERP B exceeded the Swedish Medical Equipment industry which returned 10.2% over the past year.

Return vs Market: PERP B exceeded the Swedish Market which returned 25.9% over the past year.

Price Volatility

Is PERP B's price volatile compared to industry and market?
PERP B volatility
PERP B Average Weekly Movement14.8%
Medical Equipment Industry Average Movement7.2%
Market Average Movement5.5%
10% most volatile stocks in SE Market10.9%
10% least volatile stocks in SE Market3.2%

Stable Share Price: PERP B's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: PERP B's weekly volatility has decreased from 22% to 15% over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
20074Anders Hedlundperpetuamedical.se

Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company offers DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024.

Perpetua Medical AB (publ) Fundamentals Summary

How do Perpetua Medical's earnings and revenue compare to its market cap?
PERP B fundamental statistics
Market capSEK 21.48m
Earnings (TTM)-SEK 8.48m
Revenue (TTM)SEK 6.32m

3.4x

P/S Ratio

-2.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PERP B income statement (TTM)
RevenueSEK 6.32m
Cost of RevenueSEK 3.06m
Gross ProfitSEK 3.26m
Other ExpensesSEK 11.74m
Earnings-SEK 8.48m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 22, 2024

Earnings per share (EPS)-1.88
Gross Margin51.60%
Net Profit Margin-134.28%
Debt/Equity Ratio0%

How did PERP B perform over the long term?

See historical performance and comparison